Accumulating evidence also demonstrated that the nephroprotective effects of quercetin are related to inhibiting renal tubular epithelial-mesenchymal transition and renal fibrosis and reducing the production of cytokines in DN, including IL-6, TNF-α, and IL-1β [54–56]. This evidence concerns the gene IL6 and liver dysplastic nodule.